Clover Health Investments, Corp. (CLOV) stock

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

Clover Health Investments price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Clover Health Investments's price to sales ratio was 1.1× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 1.6×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.1×	+0.4
2025	Dec 31, 2025	0.7×	−0.5
2024	Dec 31, 2024	1.1×	+0.9
2023	Dec 29, 2023	0.2×	+0.1
2022	Dec 30, 2022	0.1×	−0.9
2021	Dec 31, 2021	1.0×	−2.2
2020	Dec 31, 2020	3.2×	–

Where these numbers come from

Parsed from the XBRL in Clover Health Investments's annual and quarterly filings with the SEC
Per-share figures adjusted for the 19-for-3 split on May 17, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing